All Photos(1)

Documents

Y0000197

Ondansetron for LC system suitability

Name: Ondansetron for LC system suitability
Brand: SIAL

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

Ondansetron hydrochloride dihydrate, 1,2,3,9-Tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one hydrochloride, GR 38032F

Sign Into View Organizational & Contract Pricing

All Photos(1)

About This Item

Empirical Formula (Hill Notation):

C₁₈H₁₉N₃O · HCl · 2H₂O

CAS Number:

103639-04-9

Molecular Weight:

365.85

MDL number:

MFCD00374371

UNSPSC Code:

41116107

PubChem Substance ID:

329830879

NACRES:

NA.24

Recommended Products

Slide 1 of 8

1 of 8

Y0000196

Ondansetron for TLC system suitability

USP

1478630

Ondansetron Resolution Mixture

Y0000218

Ondansetron hydrochloride dihydrate

Y0001359

Prednisolone for peak identification

USP

1478582

Ondansetron hydrochloride

Sigma-Aldrich

O3639

Ondansetron hydrochloride dihydrate

I0360000

Ipratropium bromide

Y0000195

Ondansetron impurity D

grade

pharmaceutical primary standard

API family

ondansetron

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

SMILES string

Cl[H].[H]O[H].[H]O[H].Cc1nccn1CC2CCc3c(C2=O)c4ccccc4n3C

InChI

1S/C18H19N3O.ClH.2H2O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2;;;/h3-6,9-10,13H,7-8,11H2,1-2H3;1H;2*1H2

InChI key

VRSLTNZJOUZKLX-UHFFFAOYSA-N

Gene Information

human ... HTR3A(3359)

Looking for similar products? Visit Product Comparison Guide

Related Categories

Analytical Reference Standards

Pharmacopeia & Metrological Institute Standards

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Ondansetron for LC system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Biochem/physiol Actions

5-HT₃serotonin receptor antagonist

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

related product

Product No.

Description

Pricing

PHR1141

Ondansetron Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material

1478618

1478593

1478629

signalword

Danger

hcodes

H301,H318,H410

pcodes

P264 - P273 - P280 - P301 + P310 - P305 + P351 + P338 - P391

Hazard Classifications

Acute Tox. 3 Oral - Aquatic Acute 1 - Aquatic Chronic 2 - Eye Dam. 1

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Do children with high body mass indices have a higher incidence of emesis when undergoing ketamine sedation?

Kristi L Kinder et al.

Pediatric emergency care, 28(11), 1203-1205 (2012-11-02)

The objective of this study was to determine if overweight children are more likely than normal-weight children to require ondansetron when undergoing ketamine sedation in a pediatric emergency department. Patients between the ages of 2 and 18 years with an

Adherence to national guidelines for antiemesis prophylaxis in patients undergoing chemotherapy for lung cancer: a population-based study.

Daniel R Gomez et al.

Cancer, 119(7), 1428-1436 (2012-12-06)

Nausea and vomiting (N/V) during chemotherapy can have profound clinical and economic consequences. Effective antiemetic agents are available for prophylaxis, but barriers may prevent their use. For this population-based study, the authors assessed the rates of antiemetic prophylaxis use, and

Neuropathic mechanisms in the pathophysiology of burns pruritus: redefining directions for therapy and research.

Ioannis Goutos

Journal of burn care & research : official publication of the American Burn Association, 34(1), 82-93 (2012-11-09)

Pruritus in burn wounds is a common symptom affecting patient rehabilitation. Over the last decades, there has been a resurgence of interest into more effective strategies to combat this distressing problem; nevertheless, no reports exist in the literature to propose

Ondansetron in pregnancy and risk of adverse fetal outcomes.

Björn Pasternak et al.

The New England journal of medicine, 368(9), 814-823 (2013-03-01)

Ondansetron is frequently used to treat nausea and vomiting during pregnancy, but the safety of this drug for the fetus has not been well studied. We investigated the risk of adverse fetal outcomes associated with ondansetron administered during pregnancy. From

Thiolated xyloglucan: Synthesis, characterization and evaluation as mucoadhesive in situ gelling agent.

Hitendra S Mahajan et al.

Carbohydrate polymers, 91(2), 618-625 (2012-11-06)

The objective of present study was to enhance bioadhesive potential of xyloglucan by thiolation. Thiolation of xyloglucan was achieved with esterification with thioglycolic acid. Thiolated xyloglucan was characterized by NMR, DSC, and XRD analysis. Thiolated xyloglucan was determined to possess

View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service